Home Stock

Stock Research: DiaSorin

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

DiaSorin

MIL:DIA IT0003492391
18
  • Value
    80
  • Growth
    14
  • Safety
    Safety
    37
  • Combined
    30
  • Sentiment
    23
  • 360° View
    360° View
    18
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

DiaSorin SpA develops, produces, and commercializes reagent kits for in vitro diagnostics. The company operates in the healthcare industry, specializing in infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring, and autoimmunity. The company operates in the Immunodiagnostics and Molecular Diagnostics markets. In the last fiscal year, the company had a market cap of $5,841 million, profits of $809 million, revenue of $1,227 million, and 3271 employees.

more
Strongest Rank Growth
Weakest Rank Value
Country Italy
Industry Health Care Equipment
Size Medium
Website int.diasorin.com
Index
MIB
DiaSorin stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
80 32 23 34
Growth
14 88 21 7
Safety
Safety
37 48 50 98
Sentiment
23 60 10 90
360° View
360° View
18 80 6 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
28 13 13 19
Opinions Change
44 50 10 64
Pro Holdings
n/a 73 31 90
Market Pulse
52 75 65 89
Sentiment
23 60 10 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
80 32 23 34
Growth
14 88 21 7
Safety Safety
37 48 50 98
Combined
30 75 6 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
52 26 27 27
Price vs. Earnings (P/E)
61 34 33 31
Price vs. Book (P/B)
74 40 37 37
Dividend Yield
70 47 39 37
Value
80 32 23 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
34 73 12 12
Profit Growth
57 83 12 54
Capital Growth
17 76 100 27
Stock Returns
15 56 18 32
Growth
14 88 21 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
44 20 22 92
Refinancing
18 53 59 71
Liquidity
69 61 53 92
Safety Safety
37 48 50 98

Similar Stocks

Discover high‑ranked alternatives to DiaSorin and broaden your portfolio horizons.

STMicroelectronics

PAR:STMPA
Country: Netherlands
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

MOL

BUD:MOL
Country: Hungary
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

Ternium

NYQ:TX
Country: Netherlands
Industry: Steel
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

With good value and positive sentiment, but low growth and risky financing, this combination is generally dangerous as debt requires growth to sustain it. Only investors with a strong belief in future growth potential and a high-risk tolerance should consider this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews